Beam Therapeutics (BEAM) EBITDA Margin Growth (3y) (2022 - 2026)
Powered by 
Analysis
Beam Therapeutics (BEAM) EBITDA Margin Growth (3y) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -377.00 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -204.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 7,045.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1,934.00 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 7,261.00 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 9,003.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -2,649.00 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 30,461.00 |
| 10 | Beam Therapeutics | 3.10 Bn | 3.10 Bn | - | -2.53 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.53 Mn |
| Mar 31, 2026 | 7,085.00 |
| Dec 31, 2025 | 42,882.00 |
| Sep 30, 2025 | -72,970.00 |
| Jun 30, 2025 | -92,699.00 |
| Mar 31, 2025 | -69,287.00 |
| Dec 31, 2024 | -20,840.00 |
| Sep 30, 2024 | 837,994.00 |
| Jun 30, 2024 | 98.20 Mn |
| Mar 31, 2024 | 333.81 Mn |
| Dec 31, 2023 | 68.00 Mn |
| Sep 30, 2023 | 62.14 Mn |
| Jun 30, 2023 | 43.76 Mn |
| Mar 31, 2023 | 47.22 Mn |
| Dec 31, 2022 | 43.91 Mn |
| Sep 30, 2022 | 29.98 Mn |
| Jun 30, 2022 | 29.37 Mn |